Cargando…
High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation
BACKGROUND: High-flow nasal cannula (HFNC) is increasingly used in critically ill cancer patients with acute respiratory failure (ARF) to avoid mechanical ventilation (MV). The objective was to assess prognostic factors associated with mortality in ICU cancer patients requiring MV after HFNC failure...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242496/ https://www.ncbi.nlm.nih.gov/pubmed/35767521 http://dx.doi.org/10.1371/journal.pone.0270138 |
_version_ | 1784738072291704832 |
---|---|
author | Saillard, Colombe Lambert, Jérôme Tramier, Morgane Chow-Chine, Laurent Bisbal, Magali Servan, Luca Gonzalez, Frederic de Guibert, Jean-Manuel Faucher, Marion Sannini, Antoine Mokart, Djamel |
author_facet | Saillard, Colombe Lambert, Jérôme Tramier, Morgane Chow-Chine, Laurent Bisbal, Magali Servan, Luca Gonzalez, Frederic de Guibert, Jean-Manuel Faucher, Marion Sannini, Antoine Mokart, Djamel |
author_sort | Saillard, Colombe |
collection | PubMed |
description | BACKGROUND: High-flow nasal cannula (HFNC) is increasingly used in critically ill cancer patients with acute respiratory failure (ARF) to avoid mechanical ventilation (MV). The objective was to assess prognostic factors associated with mortality in ICU cancer patients requiring MV after HFNC failure, and to identify predictive factors of intubation. METHODS: We conducted a retrospective study from 2012–2016 in a cancer referral center. All consecutive onco-hematology adult patients admitted to the ICU treated with HFNC were included. HFNC failure was defined by intubation requirement. RESULTS: 202 patients were included, 104 successfully treated with HFNC and 98 requiring intubation. ICU and hospital mortality rates were 26.2% (n = 53) and 42.1% (n = 85) respectively, and 53.1% (n = 52) and 68.4% (n = 67) in patients requiring MV. Multivariate analysis identified 4 prognostic factors of hospital mortality after HFNC failure: complete/partial remission (OR = 0.2, 95%CI = 0.04–0.98, p<0.001) compared to patients with refractory/relapse disease (OR = 3.73, 95%CI = 1.08–12.86), intubation after day 3 (OR = 7.78, 95%CI = 1.44–41.96), number of pulmonary quadrants involved on chest X-ray (OR = 1.93, 95%CI = 1.14–3.26, p = 0.01) and SAPSII at ICU admission (OR = 1.06, 95%CI = 1–1.12, p = 0.019). Predictive factors of intubation were the absence of sepsis (sHR = 0.32, 95%CI = 0.12–0.74, p = 0.0087), Sp02<95% 15 minutes after HFNC initiation (sHR = 2.05, 95%CI = 1.32–3.18, p = 0.0014), number of quadrants on X-ray (sHR = 1.73, 95%CI = 1.46–2.06, p<0.001), Fi02>60% at HFNC initiation (sHR = 3.12, 95%CI = 2.06–4.74, p<0.001) and SAPSII at ICU admission (sHR = 1.03, 95%CI = 1.02–1.05, p<0.01). CONCLUSION: Duration of HFNC may be predictive of an excess mortality in ARF cancer patients. Early warning scores to predict HFNC failure are needed to identify patients who would benefit from early intubation. |
format | Online Article Text |
id | pubmed-9242496 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-92424962022-06-30 High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation Saillard, Colombe Lambert, Jérôme Tramier, Morgane Chow-Chine, Laurent Bisbal, Magali Servan, Luca Gonzalez, Frederic de Guibert, Jean-Manuel Faucher, Marion Sannini, Antoine Mokart, Djamel PLoS One Research Article BACKGROUND: High-flow nasal cannula (HFNC) is increasingly used in critically ill cancer patients with acute respiratory failure (ARF) to avoid mechanical ventilation (MV). The objective was to assess prognostic factors associated with mortality in ICU cancer patients requiring MV after HFNC failure, and to identify predictive factors of intubation. METHODS: We conducted a retrospective study from 2012–2016 in a cancer referral center. All consecutive onco-hematology adult patients admitted to the ICU treated with HFNC were included. HFNC failure was defined by intubation requirement. RESULTS: 202 patients were included, 104 successfully treated with HFNC and 98 requiring intubation. ICU and hospital mortality rates were 26.2% (n = 53) and 42.1% (n = 85) respectively, and 53.1% (n = 52) and 68.4% (n = 67) in patients requiring MV. Multivariate analysis identified 4 prognostic factors of hospital mortality after HFNC failure: complete/partial remission (OR = 0.2, 95%CI = 0.04–0.98, p<0.001) compared to patients with refractory/relapse disease (OR = 3.73, 95%CI = 1.08–12.86), intubation after day 3 (OR = 7.78, 95%CI = 1.44–41.96), number of pulmonary quadrants involved on chest X-ray (OR = 1.93, 95%CI = 1.14–3.26, p = 0.01) and SAPSII at ICU admission (OR = 1.06, 95%CI = 1–1.12, p = 0.019). Predictive factors of intubation were the absence of sepsis (sHR = 0.32, 95%CI = 0.12–0.74, p = 0.0087), Sp02<95% 15 minutes after HFNC initiation (sHR = 2.05, 95%CI = 1.32–3.18, p = 0.0014), number of quadrants on X-ray (sHR = 1.73, 95%CI = 1.46–2.06, p<0.001), Fi02>60% at HFNC initiation (sHR = 3.12, 95%CI = 2.06–4.74, p<0.001) and SAPSII at ICU admission (sHR = 1.03, 95%CI = 1.02–1.05, p<0.01). CONCLUSION: Duration of HFNC may be predictive of an excess mortality in ARF cancer patients. Early warning scores to predict HFNC failure are needed to identify patients who would benefit from early intubation. Public Library of Science 2022-06-29 /pmc/articles/PMC9242496/ /pubmed/35767521 http://dx.doi.org/10.1371/journal.pone.0270138 Text en © 2022 Saillard et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Saillard, Colombe Lambert, Jérôme Tramier, Morgane Chow-Chine, Laurent Bisbal, Magali Servan, Luca Gonzalez, Frederic de Guibert, Jean-Manuel Faucher, Marion Sannini, Antoine Mokart, Djamel High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation |
title | High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation |
title_full | High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation |
title_fullStr | High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation |
title_full_unstemmed | High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation |
title_short | High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation |
title_sort | high-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: moving from avoiding intubation to avoiding delayed intubation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9242496/ https://www.ncbi.nlm.nih.gov/pubmed/35767521 http://dx.doi.org/10.1371/journal.pone.0270138 |
work_keys_str_mv | AT saillardcolombe highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation AT lambertjerome highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation AT tramiermorgane highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation AT chowchinelaurent highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation AT bisbalmagali highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation AT servanluca highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation AT gonzalezfrederic highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation AT deguibertjeanmanuel highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation AT fauchermarion highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation AT sanniniantoine highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation AT mokartdjamel highflownasalcannulafailureincriticallyillcancerpatientswithacuterespiratoryfailuremovingfromavoidingintubationtoavoidingdelayedintubation |